O'Connor, D., Moorman, A., Wade, R., Hancock, J., Tan, R., Bartram, J., . . . Samarasinghe, S. (2017). Use of Minimal Residual Disease Assessment to Redefine Induction Failure in Pediatric Acute Lymphoblastic Leukemia. American Society of Clinical Oncology.
Style de citation Chicago (17e éd.)O'Connor, D., et al. Use of Minimal Residual Disease Assessment to Redefine Induction Failure in Pediatric Acute Lymphoblastic Leukemia. American Society of Clinical Oncology, 2017.
Style de citation MLA (9e éd.)O'Connor, D., et al. Use of Minimal Residual Disease Assessment to Redefine Induction Failure in Pediatric Acute Lymphoblastic Leukemia. American Society of Clinical Oncology, 2017.
Attention : ces citations peuvent ne pas être correctes à 100%.